refractory hairy cell leukemia

Dear Editor, Hairy cell leukemia (HCL) is a mature B-cell lymphoid cancer that can be treated successfully in the majority of… (More)

Hairy cell leukemia is a rare chronic lymphoproliferative disorder with indolent but progressive clinical course. Patients… (More)

PURPOSE To determine tolerability and for the first time explore efficacy of bendamustine-rituximab (BR) in multiply relapsed… (More)

Dear Editor, Hairy-cell leukemia (HCL) is a rare hematological malignancy, which typically responds very well to first-line… (More)

The purine analogs, pentostatin and cladribine, induce high remission rates when used as first-line monotherapy for hairy cell… (More)

A 72-year-old Japanese man presented with 43.1 x 10(9)/l hairy cells and apparent splenomegaly. The leukemia cells had unevenly… (More)

We report the case of a 76-year-old man with hairy cell leukemia (HCL)-Japanese variant who underwent rituximab therapy. HCL… (More)

The purpose of this study was to investigate the efficacy and safety of the monoclonal antibody, rituximab, in relapsed or… (More)

We report major responses in 4 of 4 patients with hairy cell leukemia (HCL) who have recently been treated on a phase I trial… (More)

Our experience suggests a potential role of fludarabine phosphate in the management of hairy cell leukemia. On the basis of this… (More)